Brad Gray talked to the Puget Sound Business Journal about how honing in on cancer diagnostics has already started to pay dividends. Seattle biotech NanoString Technologies (Nasdaq: NSTG) is finding ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that ...
More than a month after filing for Chapter 11 bankruptcy, NanoString Technologies has agreed to be acquired by the healthcare investment firm Patient Square Capital for $220 million pending approval ...
NanoString is an Established Leader and Valuable Innovator in Gene Expression Profiling and Spatial Transcriptomics for Scientific and Clinical Research in Healthcare Under the asset purchase ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString” or the “Company”), a leading provider of life science tools for discovery and translational research, today announced ...
Court expresses significant doubts about the validity of the patent asserted by 10x Genomics in its ongoing litigation with NanoString “We have maintained from the outset of this case that the patents ...
Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...
NanoString Technologies, joined by three of its subsidiaries, have filed for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code, blaming the $31 million jury award assessed against ...
NanoString, the Seattle-based biotech company that initiated a Chapter 11 bankruptcy process last month, announced late Sunday it agreed to a deal with healthcare investment firm Patient Square ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results